XML 61 R46.htm IDEA: XBRL DOCUMENT v3.25.3
Employee Benefit Plans (Tables)
 12 Months Ended
Oct. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Stock Units The following table contains information concerning activities related to restricted stock units granted under the 2006 Employee Plan and assumed from acquisitions including those associated with our discontinued operations:
Restricted
Stock Units Outstanding		Weighted 
Average
Grant Date
Fair Value		Weighted
Average
Remaining
Contractual
Life (In Years)		Aggregate
Fair
Value
 (in thousands, except per share amounts and years)
Balance at October 31, 2022(1)
4,638 $265.76 1.32
Granted(2)
2,083 $394.34 
Vested(3)
(1,839)$237.19 $706,136 
Forfeited(365)$283.29 
Balance at October 31, 2023(1)
4,517 $335.26 1.41
Granted(2)
1,620 $543.69 
Vested(3)
(1,778)$303.23 $962,127 
Forfeited(460)$395.74 
Balance at October 31, 2024(1)
3,899 $429.36 1.35
Assumed upon acquisition of Ansys
1,116 $571.20 
Granted(2)
1,280 $494.29 
Vested(3)
(1,753)$407.12 $865,731 
Forfeited(224)$466.51 
Balance at October 31, 20254,318 $492.36 1.05
(1)No restricted stock units were assumed in connection with acquisitions during these fiscal years.
(2)The number of granted restricted stock units includes those granted to senior management with market-based and performance-based vesting criteria in addition to service-based vesting criteria (market-based RSUs) reported at the maximum possible number of shares that may ultimately be issuable if all applicable market-based and performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied.
(3)The number of vested restricted stock units includes shares that were withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements.
Schedule of Stock Options The following table summarizes stock option activity and includes stock options granted under all equity plans including those associated with our discontinued operations:
 Options Outstanding
 
Shares Under Stock Option (1)
Weighted-
Average Exercise
Price per Share		Weighted-
Average
Remaining
Contractual
Life (In Years)		Aggregate
Intrinsic
Value
 (in thousands, except per share amounts and years)
Balance at October 31, 20222,160 $150.37 3.57$328,120 
Granted294 $361.64 
Exercised(849)$109.83 
Canceled/forfeited/expired(90)$245.86 
Balance at October 31, 20231,515 $208.49 3.70$376,563 
Granted238 $551.41 
Exercised(429)$141.83 
Canceled/forfeited/expired(42)$376.97 
Balance at October 31, 20241,282 $288.91 3.63$301,781 
Assumed upon acquisition of Ansys
5 $124.53 
Granted232 $502.29 
Exercised(323)$171.82 
Canceled/forfeited/expired(42)$463.57 
Balance at October 31, 20251,154 $357.66 3.74$141,969 
Vested and expected to vest as of October 31, 20251,154 $357.66 3.74$141,969 
Exercisable at October 31, 2025709 $279.76 2.66$131,982 
(1)The balance at fiscal year-end includes certain stock options that were previously assumed in connection with other acquisitions.
The pre-tax intrinsic value of options exercised and their average exercise prices including those associated with our discontinued operations are:
 Year Ended October 31,
 202520242023
 (in thousands, except per share price)
Intrinsic value$104,394 $185,663 $241,385 
Average exercise price per share$171.82 $141.83 $109.83 
Schedule of Restricted Stock Units and Stock Options The following table contains additional information concerning activities related to stock options and restricted stock units that were granted under the 2006 Employee Plan and assumed from acquisitions, except for the Ansys Merger, including those associated with our discontinued operations:
 
Available for Grant (1)(2)
 (in thousands)
Balance at October 31, 202213,111 
Options granted(2)
(294)
Options canceled/forfeited/expired(2)
89 
Restricted stock units granted(1)(3)
(3,540)
Restricted stock units forfeited(1)
620 
Additional shares reserved3,300 
Balance at October 31, 202313,286 
Options granted(2)
(238)
Options canceled/forfeited/expired(2)
40 
Restricted stock units granted(1)(3)
(2,754)
Restricted stock units forfeited(1)
782 
Additional shares reserved3,400 
Balance at October 31, 202414,516 
Options granted(2)
(232)
Options canceled/forfeited/expired(2)
41 
Restricted stock units granted(1)(3)
(2,176)
Restricted stock units forfeited(1)
365 
Additional shares reserved1,600 
Balance at October 31, 202514,114 
(1)Restricted stock units includes awards granted under the 2006 Employee Plan and assumed through acquisitions. The number of RSUs reflects the application of the award multiplier of 1.70 as described above. No additional options and RSUs will be granted under the Assumed Equity Plans.
(2)Options granted by us are not subject to the award multiplier ratio described above.
(3)The number of granted restricted stock units includes market-based RSUs reported at the maximum possible number of shares that may ultimately be issuable if all applicable market-based and performance-based criteria are achieved at their maximum levels and all applicable service-based criteria are fully satisfied.
Schedule of Restricted Stock Award Activities Under 2005 Directors Plan The following table summarizes restricted stock award activities under the 2017 Directors Plan:
Restricted
Shares		Weighted-Average
Grant Date Fair Value
 (in thousands, except per share amounts)
Unvested at October 31, 2022
5 $310.02 
Granted5 $387.79 
Vested(5)$310.02 
Forfeited— $— 
Unvested at October 31, 2023
5 $387.79 
Granted3 $561.23 
Vested(4)$382.88 
Forfeited— $— 
Unvested at October 31, 20244 $541.51 
Granted6 $419.34 
Vested(4)$550.58 
Forfeited— $— 
Unvested at October 31, 20256 $419.64 
Schedule of Stock Option Plans and Stock Purchase Rights Granted Under ESPP
The assumptions presented in the following table are used to estimate the fair value of stock options and employee stock purchase rights granted under our stock plans:
 Year Ended October 31,
 202520242023
Stock Options:
Expected life (in years)
4.1
4.1
4.1
Risk-free interest rate
3.53%- 4.53%
3.62% - 4.61%
3.80% - 4.80%
Volatility
34.84% -42.33%
32.09% - 35.42%
32.74%- 36.16%
Weighted average estimated fair value
$170.77
$178.67
$120.33
ESPP:
Expected life (in years)
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Risk-free interest rate
3.66% - 4.31%
3.88% - 5.27%
4.85% - 5.38%
Volatility
34.69% - 38.34%
31.40% - 34.39%
28.03% - 35.27%
Weighted average estimated fair value
$166.64
$179.10
$120.82
Schedule of Share-Based Payment Award, Restricted Stock Units, Valuation Assumptions
The grant date fair value of the market-based RSUs and the assumptions used in the Monte Carlo simulation model to determine the grant date fair value during the periods are as follows:
 Year Ended October 31,
 202520242023
Expected life (in years)
2.67 - 2.79
 2.89
0.90 - 2.70
Risk-free interest rate
3.90% - 4.39%
4.41%
4.36% - 4.80%
Volatility
33.40% - 34.72%
34.03%
34.79% - 42.86%
Grant date fair value
$409.94 - $464.17
$600.29
$357.29 - $465.79
Schedule of Stock Compensation Expense
The compensation cost recognized in the consolidated statements of income for our stock compensation arrangements is as follows:
 Year Ended October 31,
 
2025(1)
20242023
 (in thousands)
Cost of products$89,366 $66,403 $49,896 
Cost of maintenance and service41,897 32,189 29,572 
Research and development expense456,804 359,244 282,540 
Sales and marketing expense178,384 121,524 91,082 
General and administrative expense126,843 78,575 60,004 
Stock-based compensation expense from continuing operations before taxes893,294 657,935 513,094 
Stock-based compensation expense from discontinued operations before taxes— 34,381 50,198 
Total stock-based compensation expense before taxes893,294 692,316 563,292 
Income tax benefit(134,441)(115,271)(90,915)
Stock-based compensation expense after taxes$758,853 $577,045 $472,377 
(1)Includes $150.5 million of stock-based compensation expense related to the Assumed Equity Awards in connection with the Ansys Merger.
Schedule of Deferred Plan Assets and Liabilities
Deferred plan assets and liabilities are as follows:
As of October 31,
20252024
 (in thousands)
Plan assets recorded in other long-term assets$447,232 $386,757 
Plan liabilities recorded in other long-term liabilities(1)
$447,232 $386,757 
(1)Undistributed deferred compensation balances due to participants.
Schedule of Impact of Deferred Plan The following table summarizes the impact of the Deferred Plan:
 Year Ended October 31,
 202520242023
 (in thousands)
Increase (reduction) to cost of revenue and operating expense$65,492 $85,446 $20,196 
Interest and other income (expense), net
65,492 85,446 20,196 
Net increase (decrease) to net income$— $— $—